


下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEXMD8-87Cat. No.: HY-15811CAS No.: 1234480-46-6Synonyms: ACK1-B19分式: CHNO分量: 445.52作靶點(diǎn): Tyrosinase作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 26 mg/mL (58.3
2、6 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (4.67 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.08 mg/mL (4.67 mM); Suspended solution; Need ultrasonicBIOLOGICAL ACTIVITY物活性 XMD8-87種有效的TNK2抑制劑
3、,對(duì)于D163E和R806Q突變體的IC50值分別為38和113 nM。IC50 & Target IC50: 38 nM (TNK2, D163E mutation), 113 nM (TNK2, R806Q mutation) 1體外研究 XMD8-87 potently inhibits the growth of the TNK2 mutant expressing cell lines while having little or no effecton the control cells out to the highest tested concentrations (1,000
4、 nM). XMD8-87 has IC50s of 38 nM and113 nM for the D163E and R806Q mutations. The effects of XMD8-87 on TNK2 cell lines are largely due toon-target effects on TNK2. Auto-phosphorylation of overexpressed TNK2 mutants could be blocked withTNK2 inhibitor XMD8-87 1.PROTOCOLKinase Assay 1 Kinase targets
5、are tested with biochemical enzymatic kinase assays using the SelectScreen Kinase ProfilingService to determine IC50 values. The compounds (XMD8-87) are assayed at 10 concentrations (3-foldserial dilutions starting from 1 M) at an ATP concentration equal to the ATP Km 1.MCE has not independently con
6、firmed the accuracy of these methods. They are for reference only.Cell Assay 1 Cells are treated with the following inhibitors for 72 hours: dasatinib, AIM-100, XMD8-87 and XMD16-5. Cellviability is measured using a methanethiosulfonate (MTS)-based assay and absorbance (490 nm) is read at 1and 3 hou
7、rs after adding reagent 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Maxson JE, et al. Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration ofKinase Inhibitor Screening and Genomic Analysis.McePdfHeightCaution: Product has not been fully validated for medical applications.For research
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 管理學(xué)崗位設(shè)置
- 法醫(yī)臨床檢驗(yàn)規(guī)范
- 電商退換貨快遞服務(wù)協(xié)議
- 鐘表店翻新拆舊協(xié)議
- 物聯(lián)網(wǎng)在智能交通管理中的創(chuàng)新方案
- 家政安保居間服務(wù)協(xié)議
- 股東向公司借款合同范本
- 2024浙江信息工程學(xué)校工作人員招聘考試及答案
- 2024湖南三一工業(yè)職業(yè)技術(shù)學(xué)院工作人員招聘考試及答案
- 鋼材采購(gòu)合同協(xié)議
- 新加坡可變資本公司VCC指南 -BBCG出版
- 2025年春季學(xué)期學(xué)校德育工作計(jì)劃安排表(完整版)
- 木質(zhì)埡口施工方案
- 石油化工項(xiàng)目監(jiān)理總結(jié)報(bào)告
- 三類人員B證考試題庫(kù)及答案集合
- 第13課 立足專業(yè) 謀劃發(fā)展(課件)-【中職專用】高一思想政治《心理健康與職業(yè)生涯》
- 化驗(yàn)室安全隱患及防范措施
- 合肥市2025屆高三第二次模擬考試英語(yǔ)試卷含解析
- 部編版語(yǔ)文一年級(jí)下冊(cè)第一單元教材解讀
- 《亞馬遜運(yùn)營(yíng)知識(shí)》課件
- 蔬菜大棚建設(shè)投標(biāo)方案技術(shù)標(biāo)范本
評(píng)論
0/150
提交評(píng)論